Based on these findings, we concluded that the potential bias arising from the increased use of warfarin might not be significant in our analysis.
← all excerpts
Impact of components of metabolic syndrome on the risk of adverse renal outcomes in patients with atrial fibrillation: a nationwide cohort study.
1
—
—